Showing 2011-2020 of 2813 results for "".
- Galderma Set to Start Seven New Clinical Studieshttps://modernaesthetics.com/news/galderma-set-to-start-begin-seven-new-clinical-studies/2472838/Galderma is initiating seven clinical studies that seek to support potential, new aesthetic indications including a tear trough indication for Restylane, a facial wrinkles indication for Sculptra Aesthetic as well as several studies supporting an investigational liquid neurotoxin and a Phase 2 st
- Merz: Cellfina for Cellulite Cleared for 5 Years of Benefithttps://modernaesthetics.com/news/merz-cellfina-for-cellulite-cleared-for-5-years-of-benefit/2472836/The FDA has cleared a new indication statement for Cellfina that shows the benefits of treatment last for five years, an increase from the previous three-year indication. Cellfina from Merz demonstrated five-year improvement in the appearance of cellulite on the buttocks and thighs of adult femal
- Daily Almond Consumption May Reduce Facial Wrinkleshttps://modernaesthetics.com/news/daily-almond-consumption-may-reduce-facial-wrinkles-1/2472824/Snacking on almonds may help postmenopausal women smooth wrinkles from the inside out, according to a new study funded by the Almond Board of California. In this 16-week randomized con
- FDA Approves Juvéderm Voluma XC For Mid-Face Injection Via Cannulahttps://modernaesthetics.com/news/fda-approves-juvderm-voluma-xc-for-mid-face-injection-via-cannula/2471976/Allergan’s Juvéderm Voluma XC is now U.S. Food and Drug Administration (FDA)-approved for cheek augmentation in the mid-face in adults over 21 with a TSK Steriglide cannula. This cannula features a patented tip design with a near-tip delivery port for precise product p
- ASDS 2018 Data: Skin Cancer Treatments, Cosmetic Procedures Are on the Risehttps://modernaesthetics.com/news/asds-2018-data-skin-cancer-treatments-cosmetic-procedures-are-on-the-rise/2471977/American Society for Dermatologic Surgery (ASDS) member dermatologists performed more than 12.5 million medical and cosmetic procedures in 2018 – 7.5 percent more than 2017 and a 60 percent increase since 2012, according to the 2018 ASDS
- Soliton RAP Update: First Patients Treated in Cellulite Trialhttps://modernaesthetics.com/news/soliton-rap-update-first-patients-treated-in-cellulite-trial/2471872/The first patients in Soliton’s cellulite trial have been treated, the Company reports. "Patient treatments have now begun at the Chicago site,” says Dr. Chris Capelli, President, CEO and co-founder of
- Sciton Targets Veins, Skin, and Hair with Clear Suite Familyhttps://modernaesthetics.com/news/sciton-targets-veins-skin-and-hair-with-clear-suite-family/2471876/Sciton Inc. is launching its Clear Suite family of products. The Clear Suite offerings make the JOULE platform customizable. Utilizing the 1064 Nd:YAG wavelength, the Clear Suite family of products, including ClearV, ClearSilk, and ClearHair, combined with BroadBand Light (BBL), allo
- Viper Equity Partners Moves Plastic Surgery Into Consolidation Mainstream with Another Marquis Dealhttps://modernaesthetics.com/news/viper-equity-partners-moves-plastic-surgery-into-consolidation-mainstream-with-another-marquis-deal/2471886/Plastic Surgery is moving into the consolidation Mainstream with another marquis deal by Viper Equity Partners of Palm Beach, FL. Viper was instrumental in a Marquis deal merging their client Aqua Plastic Surgery with Water's Edge Derma
- Cutera Introduces truSculpt flex for Toning Abs, Butts and Thighshttps://modernaesthetics.com/news/cutera-introduces-trusculpt-flex-for-toning-abs-butts-and-thighs/2471887/Cutera is launching the new truSculpt flex, muscle sculpting platform in the United States, and commercial shipments are slated to begin immediately. truSculpt flex is FDA-cleared for the indications of the improvement of abdominal tone, strengthening
- Dominion Aesthetic Technologies, Inc.'s Body Contouring Laser Scores FDA Nodhttps://modernaesthetics.com/news/dominion-aesthetic-technologies-incs-eon-fr-scores-fda-nod/2471891/The FDA has cleared